News
Latest
News
Eur. Ph. revises monographs to aid detection of adulterated excipients
The new gas chromatography test strengthens quality control within the pharmaceutical supply chain as well as availability of safe, high-quality medicines, particularly for children.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
NewsSanofi trims mature medicines portfolio and divests of three manufacturing sites
Divestment agreement expands decade-long collaboration between Sanofi and Cheplapharm, helps to hone Sanofi’s innovation focus.
NewsNovo Nordisk tightens obesity market focus with ‘Novo’ name change
The Danish pharmaceutical giant hopes the strategic rebranding and modernising its culture will sharpen the company’s competitive edge in the rapidly evolving obesity and diabetes therapeutics landscape.
NewsLonza expands large-scale spray-drying capacity in Oregon, US
New PSD-4 facility creates a global manufacturing hub for commercial spray-drying and addresses rising demand for bioavailability enhancement solutions across small molecules, biologics and mRNA modalities.
NewsSimultaneous anaerobic bioreactor could accelerate sustainable biomanufacturing
Study suggests that enrichment of cellulose-degraders in the baffled compartments can aid stable co-digestion of high-strength wastewater and solid organic waste from biomanufacturing processes.
More news
News
Strengthening female participation in clinical trials with AI-driven eConsent
In-depth: Study results highlight the growing momentum towards more real-time and technology-enabled clinical trials in the pharmaceutical industry and facilitates increased enrollment of female patients.
News
Atmospheric NOâ‚“ may contribute to NDSRI formation, study shows
Findings illustrate practical implications for risk assessment and control of nitrosamine formation in solid oral product manufacturing.
News
EFPIA and EAHP issue joint guidance on single unit barcode coding
Joint recommendations set out a phased roadmap for single unit barcoding of medicines across Europe, aimed at reducing medication errors at the point of care.
News
FDA opens consultation on regulation of botanical drug products
Agency’s call for feedback intended to support advancement of botanical drugs to expand beyond the four currently approved products in the US market.
News
Chiesi advances carbon-minimal inhaler programme with European regulatory submissions
Chiesi advances its carbon-minimal inhaler programme with European regulatory submissions for next-generation HFA-152a pressurised metered-dose inhalers.
News
Ph. Eur. adopts new general chapter for phenolic antioxidant analysis
General chapter 2.5.46. introduces a single HPLC-UV method for simultaneous determination of seven plastic additives, streamlining compliance for pharmaceutical packaging materials.
News
CPHI Pharma Awards 2026 finalists announced
Winners of this year’s awards will be revealed during the opening of CPHI Milan 2026.
News
International parallel regulatory review aids acceleration of innovative manufacturing for LAL/rFc
Milestone shifts how global pharmaceutical manufacturers approach post-approval life cycle management for medicines.
News
Use of Bunsen burners for laboratory asepsis context-dependent, study finds
Findings challenge routine use of the technique in laboratories to reduce airborne microbial contamination.
News
New Phase III Tezspire data signals advance in epithelial-driven inflammatory disease treatment
First-in-class monoclonal antibody significantly improved both underlying inflammation and dysphagia in eosinophilic esophagitis, extending its potential beyond the airways to the oesophagus.
News
FDA approves first-in-class oral RAS inhibitor for pancreatic cancer
US authorisation illustrates how targeted therapies can reshape outcomes in cancer patients even in the most aggressive forms of the disease.
News
Genentech licenses Hanmi’s UCN2 obesity candidate in $2.3bn deal
Potential first-in-class treatment HM17321 offers a non-incretin mechanism of action and differentiated profile from existing GLP-1-based treatments for obesity.